This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Cahn, R. Articles by Cahn, J. Search for Related Content PubMed PubMed Citation Articles by Cahn, R. Articles by Cahn, J.

Stroke, Vol 20, 652-656, Copyright © 1989 by American Heart Association

ARTICLES

Influence of monosialoganglioside inner ester on neurologic recovery after global cerebral ischemia in monkeys

R Cahn, MG Borzeix, C Aldinio, G Toffano and J Cahn
Department of Experimental Therapy, SIR international, Montrouge, France.

We assessed the consequences of transitory global cerebral ischemia and the influence of monosialoganglioside inner ester (AGF 2) treatment on neurologic outcome, cerebral blood flow, and cerebral metabolic rate in monkeys over 48 hours. Global cerebral ischemia was produced by a cervical tourniquet and a lowering of blood pressure to 6.65 kPa; recirculation followed after 30 minutes. AGF 2 (30 mg/kg) was administered intravenously immediately after initiation of recirculation and intramuscularly twice a day for 48 hours. Our results show that treatment with AGF 2 significantly accelerated the rate of neurologic recovery. Improvement was evident 5 hours after ischemia; full neurologic recovery was observed in half of the monkeys 48 hours after ischemia. This recovery was associated with a less severe reduction in cerebral blood flow without a concomitant increase in the cerebral metabolic rate.